Fozal

Fozal

alfuzosin

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc
Concise Prescribing Info
Contents
Alfuzosin HCl
Indications/Uses
Treatment of signs & symptoms of benign prostatic hyperplasia (BPH). As adjunct therapy w/ urethral catheterization for acute urinary retention related to BPH & management following catheter removal.
Dosage/Direction for Use
BPH & acute urinary retention 10 mg once daily.
Administration
Should be taken with food: Take immediately after the same meal each day. Swallow whole, do not chew/crush/divide.
Special Precautions
Avoid situations where injury could result should syncope occur. Patients w/ symptomatic hypotension or patients who have had a hypotensive response to other medications; congenital or acquired QT prolongation. Discontinue treatment if symptoms of angina pectoris appear or worsen. Evaluate patients prior to starting treatment to rule out the presence of prostatic carcinoma. Intraop floppy iris syndrome has been reported. Avoid hazardous tasks including driving & operating machinery as may potentially cause vertigo, dizziness & asthenia. Hepatic & renal insufficiency.
Adverse Reactions
Dizziness/faintness, headache, vertigo, malaise, drowsiness; upper resp tract infection, bronchitis, sinusitis, rhinitis, laryngitis, pharyngitis, flu-like symptoms; abdominal pain, dyspepsia, constipation, nausea, vomiting, diarrhea, dry mouth; pain, asthenia, back pain, neuralgia, neuropathy, lumbar disc lesion, joint disorders including arthritis, arthrosis, arthropathy, arthralgia, bursitis; hepatocellular & cholestatic liver injury; impotence, priapism, ejaculation disorders; rash, urticaria, angioedema, pruritus; tachycardia, palpitations, chest pain, angina pectoris in patients w/ preexisting CAD, & other symptoms associated w/ orthostasis eg, hypotension or postural hypotension & syncope; isolated spontaneous cases of QT interval prolongation, ventricular arrhythmias, including torsades de pointes, ventricular tachycardia & fibrillation; IFIS during cataract surgery in some patients on or previously treated w/ α1-blockers, abnormal vision; fatigue, edema, flushing, bite, inflicted injury, pain.
Drug Interactions
Increased risk of hypotension/postural hypotension & syncope w/ antihypertensives or nitrates.
MIMS Class
Drugs for Bladder & Prostate Disorders
ATC Classification
G04CA01 - alfuzosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.
Presentation/Packing
Form
Fozal MR tab 10 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in